Why the study?
Do Xuefu Zhuyu and Shengmai capsules improve traditional syndromes and reduce inflammatory markers in patients with unstable angina pectoris after PCI compared to placebo?
Population
90 patients with unstable angina pectoris (UAP) after percutaneous coronary intervention (PCI)
Comparison
Xuefu Zhuyu capsule or Shengmai capsule vs Placebo
Design
RCT, Randomly and equally assigned to three groups
Follow-up
12 weeks
Authors
Loading...
Supports adjunctive XFZY and SM after PCI to stabilize TCM syndromes and reduce inflammation; extends evidence for integrative approaches in unstable angina.
Do Xuefu Zhuyu and Shengmai capsules improve traditional syndromes and reduce inflammatory markers in patients with unstable angina pectoris after PCI compared to placebo?
Xuefu Zhuyu and Shengmai capsules may modulate traditional Chinese medicine syndromes and reduce inflammatory markers in patients with unstable angina after PCI.
Wang et al. (2013) studied this question.